Bristol-Myers Squibb Reveals Regulatory Approvals For Opdivo Marketing Application

By: via Benzinga
Bristol-Myers Squibb Company (NYSE: BMY) disclosed that the FDA and the European Medicines Agency have accepted their marketing ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.